These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6811078)

  • 1. Myopathy due to mercaptopropionyl glycine.
    Hales DS; Scott R; Lewi HJ
    Br Med J (Clin Res Ed); 1982 Oct; 285(6346):939. PubMed ID: 6811078
    [No Abstract]   [Full Text] [Related]  

  • 2. Myopathy due to mercaptopropionyl glycine.
    Mansell MA
    Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1356-7. PubMed ID: 6812710
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of cystinuria with alpha-mercaptopropionylglycine.
    Johansen K; Gammelgård PA; Jørgensen FS
    Scand J Urol Nephrol; 1980; 14(2):189-92. PubMed ID: 7209424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotic syndrome occurring during tiopronin treatment for cystinuria.
    Tasic V; Lozanovski VJ; Ristoska-Bojkovska N; Sahpazova E; Gucev Z
    Eur J Pediatr; 2011 Feb; 170(2):247-9. PubMed ID: 20924604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome during treatment with alpha-mercaptopropionylglycine.
    Rizzoni G; Pavanello L; Dussini N; Chiandetti L; Zacchello G
    J Urol; 1979 Sep; 122(3):381-2. PubMed ID: 470014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus foliaceus and proteinuria induced by alpha-mercaptopropionylglycine.
    Lucky PA; Skovby F; Thier SO
    J Am Acad Dermatol; 1983 May; 8(5):667-72. PubMed ID: 6863624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Mercaptopropionate, a novel metabolite formed during treatment with 2-mercaptopropionyl-glycine in cystinuria.
    Mårtensson J; Denneberg T; Kågedal B
    Eur J Clin Pharmacol; 1986; 31(1):119-21. PubMed ID: 3780820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystinuria in children.
    Pavanello L; Rizzoni G; Dussini N; Zacchello G; Passerini G; Tasca A; Pagano F
    Eur Urol; 1981; 7(3):139-43. PubMed ID: 7202450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mercaptopropionylglycine: a progress in cystine stone therapy.
    Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W
    J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia caused by tiopronin during treatment of rheumatoid polyarthritis].
    Menkes CJ; Job-Deslandre C; Bauer-Vinassac D; Rouillon A; Rousseau R
    Presse Med; 1988 Jun; 17(22):1156-7. PubMed ID: 2969543
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study of drug eruptions due to tiopronin].
    Ichikawa S; Shida Y; Nagano I; Shimizu M
    Nihon Hifuka Gakkai Zasshi; 1988 Jan; 98(1):1-8. PubMed ID: 2969988
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of nephrotic syndrome due to alpha-mercaptopropionyl glycine in a patient with familial cystinuria.
    Shibasaki T; Murai S; Kodama K; Nakano H; Ishimoto F; Sakai O
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):933-7. PubMed ID: 2250412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiopronin (N-[2-mercaptopropionyl] glycin) in rheumatoid arthritis.
    Amor B; Mery C; de Gery A
    Arthritis Rheum; 1982 Jun; 25(6):698-703. PubMed ID: 7046758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotic syndrome induced by tiopronin: association with the HLA-DR3 antigen.
    Salvarani C; Macchioni P; Rossi F; Iori I; Filippi G
    Arthritis Rheum; 1985 May; 28(5):595-6. PubMed ID: 3873945
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pemphigus induced by alpha-mercaptopropionylglycine].
    Meunier L; Krause E; Guillot B; Barneon G; Sany J; Meynadier J
    Presse Med; 1988 Apr; 17(13):647. PubMed ID: 2966940
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria.
    Harbar JA; Cusworth DC; Lawes LC; Wrong OM
    J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics.
    Ferraccioli GF; Peri F; Nervetti A; Mercadanti M; Cavalieri F; Dall'Aglio PP; Savi M; Ferrari C
    Clin Exp Rheumatol; 1986; 4(1):9-15. PubMed ID: 3516496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidemia associated with alpha-mercaptopropionylglycine therapy for cystinuria.
    Siskind MS; Popovtzer MM
    Am J Kidney Dis; 1992 Feb; 19(2):179-80. PubMed ID: 1739102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus like syndrome induced by 2-mercaptopropionylglycine.
    Katayama I; Nishioka K
    J Dermatol; 1986 Apr; 13(2):151-3. PubMed ID: 3531274
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced bullous lichen planus in a patient with diabetes mellitus and liver disease.
    Hsiao L; Yoshinaga A; Ono T
    J Am Acad Dermatol; 1986 Jul; 15(1):103-5. PubMed ID: 3522669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.